Professor Robert MacLaren, who led the gene therapy operations at Oxford Eye Hospital, said his team are "absolutely delighted" with the results so far.
It is still too early to know if the gene therapy treatment will last indefinitely, but we can say that the vision improvements have been maintained for as long as we have been following up the patients, which is two years in one case.
In truth, we did not expect to see such dramatic improvements in visual acuity and so we contacted both patients' home opticians to get current and historical data on their vision in former years, long before the gene therapy trial started.
These readings confirmed exactly what we had seen in our study and provided an independent verification.
Preliminary results from the first six patients taking part in a Phase One trial surprised the Oxford University team.
More top news
A list of commemorative events as the UK marks a decade to the day 52 were killed and hundreds injured in London terror attacks.
Larger stores could be allowed to open beyond the current six-hour limit on Sundays under a relaxation of rules in Wednesday's Budget.
IS is now attracting women and whole families as well as young men - but will any return to carry out another 7/7?